{
    "Trade/Device Name(s)": [
        "Multi-Drug Urine Test Cup",
        "Multi-Drug Urine Test Panel",
        "Wondfo Multi-Drug Urine Test Cup",
        "Wondfo Multi-Drug Urine Test Panel"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K122904",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112071"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO",
        "DKZ",
        "LDJ",
        "LAF",
        "DJR",
        "DJG",
        "LFG",
        "JXM",
        "LCM",
        "DIS"
    ],
    "Summary Letter Date": "November 15, 2012",
    "Summary Letter Received Date": "October 25, 2012",
    "Submission Date": "October 22, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3620",
        "21 CFR 862.3650",
        "21 CFR 862.3910",
        "21 CFR 862.3170",
        "21 CFR 862.3150"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Cannabinoids Test System",
        "Cocaine and cocaine metabolite test system",
        "Methamphetamine Test System",
        "Methadone Test System",
        "Morphine Test System",
        "Tricyclic antidepressant drug test system",
        "Benzodiazepine Test System",
        "Barbiturate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Secobarbital",
        "Oxazepam",
        "Cocaine",
        "Cannabinoids",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Methadone",
        "Phencyclidine",
        "Notriptyline",
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Panel",
        "Cup",
        "Dip card"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo Multi-Drug Urine Test Cup and Panel for qualitative simultaneous detection of multiple drugs of abuse in human urine using lateral flow immunochromatographic assay.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of Amphetamine, Secobarbital, Oxazepam, Cocaine, Cannabinoids, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Phencyclidine, Notriptyline, and Oxycodone in human urine at specified cutoff concentrations as a preliminary screening method.",
    "fda_folder": "Toxicology"
}